NDC 71335-1424

Tamoxifen Citrate

Tamoxifen Citrate

Tamoxifen Citrate is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is Tamoxifen Citrate.

Product ID71335-1424_62ec5985-9a78-4a17-bc82-47f1cd676935
NDC71335-1424
Product TypeHuman Prescription Drug
Proprietary NameTamoxifen Citrate
Generic NameTamoxifen Citrate
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2018-01-03
Marketing CategoryANDA / ANDA
Application NumberANDA206694
Labeler NameBryant Ranch Prepack
Substance NameTAMOXIFEN CITRATE
Active Ingredient Strength20 mg/1
Pharm ClassesEstrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 71335-1424-1

30 TABLET, FILM COATED in 1 BOTTLE (71335-1424-1)
Marketing Start Date2021-12-28
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 71335-1424-1 [71335142401]

Tamoxifen Citrate TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA206694
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-12-10

NDC 71335-1424-5 [71335142405]

Tamoxifen Citrate TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA206694
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-12-10

NDC 71335-1424-4 [71335142404]

Tamoxifen Citrate TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA206694
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-12-10

NDC 71335-1424-6 [71335142406]

Tamoxifen Citrate TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA206694
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-12-10

NDC 71335-1424-3 [71335142403]

Tamoxifen Citrate TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA206694
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-12-10

NDC 71335-1424-2 [71335142402]

Tamoxifen Citrate TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA206694
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-12-10

Drug Details

Active Ingredients

IngredientStrength
TAMOXIFEN CITRATE20 mg/1

Pharmacological Class

  • Estrogen Agonist/Antagonist [EPC]
  • Selective Estrogen Receptor Modulators [MoA]

NDC Crossover Matching brand name "Tamoxifen Citrate" or generic name "Tamoxifen Citrate"

NDCBrand NameGeneric Name
0179-0224Tamoxifen CitrateTamoxifen Citrate
0378-0144Tamoxifen CitrateTamoxifen Citrate
0378-0274Tamoxifen CitrateTamoxifen Citrate
0591-2472Tamoxifen CitrateTamoxifen Citrate
0591-2473Tamoxifen CitrateTamoxifen Citrate
50090-0485Tamoxifen CitrateTamoxifen Citrate
50090-0942Tamoxifen CitrateTamoxifen Citrate
51407-439Tamoxifen CitrateTamoxifen Citrate
51407-440Tamoxifen CitrateTamoxifen Citrate
51862-446Tamoxifen CitrateTamoxifen Citrate
51862-447Tamoxifen CitrateTamoxifen Citrate
51862-449Tamoxifen CitrateTamoxifen Citrate
51862-450Tamoxifen CitrateTamoxifen Citrate
51862-642Tamoxifen CitrateTamoxifen Citrate
51862-643Tamoxifen CitrateTamoxifen Citrate
59651-299Tamoxifen CitrateTamoxifen Citrate
59651-300Tamoxifen CitrateTamoxifen Citrate
60429-909Tamoxifen CitrateTamoxifen Citrate
60429-910Tamoxifen CitrateTamoxifen Citrate
68382-827Tamoxifen CitrateTamoxifen Citrate
68382-826Tamoxifen CitrateTamoxifen Citrate
70518-1881Tamoxifen CitrateTamoxifen Citrate
70771-1184Tamoxifen CitrateTamoxifen Citrate
70771-1185Tamoxifen CitrateTamoxifen Citrate
71335-0237Tamoxifen CitrateTamoxifen Citrate
71335-0893Tamoxifen CitrateTamoxifen Citrate
71335-0662Tamoxifen CitrateTamoxifen Citrate
63187-976Tamoxifen CitrateTamoxifen Citrate
63739-269Tamoxifen CitrateTamoxifen Citrate
65084-269Tamoxifen CitrateTamoxifen Citrate
68071-5005Tamoxifen CitrateTamoxifen Citrate
71335-1424Tamoxifen CitrateTamoxifen Citrate
68071-5254Tamoxifen CitrateTamoxifen Citrate
70518-2721Tamoxifen CitrateTamoxifen Citrate
51862-682SOLTAMOXTAMOXIFEN CITRATE
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.